CHU de Toulouse, Hôpital Purpan
Toulouse 31059
1 studies enrolling now · 4 studies all time
What they study most
Acute Myeloid Leukemia (AML), Multiple Sclerosis, Relapsing-Remitting, Parkinson's Disease
Studies at this site
- A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease — Recruiting now
- An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab — Completed
- Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML) — Completed
- Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD) — Completed